The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT

The role of the kidney in heart failure

(2012) M. Metra et al.   EUROPEAN HEART JOURNAL

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study

(2012) J. S. Borer et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure

(2011) Kevin Damman et al.   HEART

Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality

(2010) Kevin Damman et al.   EUROPEAN JOURNAL OF HEART FAILURE

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure

(2009) Inder S. Anand et al.   CIRCULATION

Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients

(2009) M. Bohm et al.   EUROPEAN HEART JOURNAL

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the IfInhibitor Ivabradine Trial (SHIFT)

(2009) Karl Swedberg et al.   EUROPEAN JOURNAL OF HEART FAILURE

Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH)

(2009) Kevin Damman et al.   EUROPEAN JOURNAL OF HEART FAILURE

Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH

(2009) Michael Böhm et al.   JOURNAL OF HYPERTENSION

Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice

(2008) A Drouin et al.   BRITISH JOURNAL OF PHARMACOLOGY

Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice

(2008) Florian Custodis et al.   CIRCULATION

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

(2008) Kim Fox et al.   LANCET